SPEAC https://validator.w3.org/feed/docs/rss2.html SPEAC and CEPI members participated in the 23rd annual conference of the International Society of Pharmacovigilance ISoP News Publications Validating a proposed case definition for Vaccine-Induced Immune Thrombocytopenia and Thrombosis Report of a SPEAC webinar 22 September 2023: Sensorineural hearing loss, Lassa virus disease and vaccines. Burden of Lassa fever disease in pregnant women and children and options for prevention Home AESI Lists Mpox Living Systematic Review on safety of Chikungunya vaccines now available New Companion Guide for Single Organ Cutaneous Vasculitis (SOCV) Rift Valley Fever Myocarditis and pericarditis Acute Encephalitis – CG Acute respiratory distress syndrome (ARDS) Anaphylaxis Anaphylaxis – CG Acute Respiratory Distress Syndrome (ARDS)-companion-guide – CG Guillain Barré and Miller Fisher Syndromes – CG Generalised Convulsion – CG Thrombocytopenia – CG Case Definition Companion Guides Preterm Birth and Assessment of Gestational Age – CG Myocarditis and Pericarditis – CG Living Systematic Reviews Spontaneous Abortion and Ectopic Pregnancy – CG Our Team Acute Aseptic Arthritis Marburg SPEAC Work Packages Nipah Lassa Fever Chikungunya Vaccine Safety Resources for Mpox Updated AESI List for Mpox Now Available DSMB Support Tools MERS COVID-19 About Us Vaccine Safety Templates SPEAC Executive Board meets with CEPI and Meta-DSMB in London  TTS and VITT – CG Women in vaccine safety work to accelerate progress toward vaccine acceptance SPEAC experts join International Neonatal and Maternal Immunization Symposium Webinar: Use of Background Rates of AESI for COVID-19 Acute Disseminated Encephalomyelitis SPEAC experts join the World Vaccine Congress Initial AESI List for mpox now available  Anosmia